A combination of herbs in Nigeria should be evaluated further as it offers potential to treat malaria, which is endemic in the country.
Academic rigor, journalistic flair
Articles on Malaria drug
Displaying all articles
The countries share related populations, economies, ecologies and epidemiologies. This interconnectedness highlights challenges and opportunities for more effective malaria control across the region.
The South African Malaria Control Programme is one of the few on the continent that is entirely funded by government. The stable source of funding has allowed for steady malaria control interventions.
Nigeria must invest more in research and incorporate World Health Organisation-recommended interventions to eliminate malaria.
Genetic diversity of a parasite population might help us watch for drug-resistant parasites.
A new study not only shows that the malarial drug chloroquine doesn’t block SARS-CoV-2 from infecting lung cells, but also explains why.
Top contributors
-
Associate professor, Federal University, Oye Ekiti
-
UP ISMC: Project Manager and Coordinator, University of Pretoria
-
Medical scientist, National Institute for Communicable Diseases
-
Dean: Faculty of Health Sciences and Director: UP Institute for Sustainable Malaria Control, University of Pretoria
-
Professor of Chemistry and Biochemistry and President-Elect of the International Society for Antiviral Research, University of Maryland, Baltimore County
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Professor, University of Ibadan
-
Professor of Pharmacology, University of Ibadan
-
Lecturer, University of Lagos
